SmileDirectClub Inc

SmileDirectClub Inc

  • Price (USD)0.975
  • Today's Change0.05 / 5.41%
  • Shares traded460.66k
  • 1 Year change-80.81%
  • Beta--
Data delayed at least 15 minutes, as of Oct 04 2022 15:15 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

SmileDirectClub, Inc. is an oral care company and creator of the medtech platform for teeth straightening. Through its teledentistry technology and vertically integrated model, it provides aligner therapy and oral care product lines. Its aligner treatment addresses the orthodontics market. The Company offers a suite of ancillary oral care products, such as retainers, toothbrushes, toothpaste, water flosser, SmileSpa, lip balm, MoveMints, BrightOn premium whitening, and a light-emitting diode (LED) accelerator light. It provides consumers with an end-to-end solution to keep teeth brighter, straighter, and healthier, with offerings in teeth whitening, electric brushes, and power flossing. Its software platform, SmileCheck, provides communication between its members and their treating doctors, and the clinical and customer care teams. It has a network of approximately 188 SmileShops and approximately 60 popup locations monthly, as well as partnerships with over 650 dental practices.

  • Revenue in USD (TTM)541.41m
  • Net income in USD-99.54m
  • Incorporated2019
  • Employees3.20k
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
ZimVie Inc-100.00bn-100.00bn263.97m2.70k--0.3452----------29.31------------------------1.41--0.4196--11.20--46.79------
Sight Sciences Inc59.90m-80.21m297.44m212.00--1.55--4.97-1.75-1.751.314.010.40852.606.90282,528.30-54.70---60.08--83.68---133.92--16.38-17.120.1468--77.12---81.48------
Edap Tms SA (ADR)48.57m2.44m298.92m227.00134.085.51--6.150.06170.06171.331.500.64863.483.74213,963.303.25-0.19234.20-0.288143.1143.555.01-0.24863.18--0.1075--5.774.35141.08-28.860.5449--
Agape ATP Corp1.22m-2.26m302.56m36.00--119.79--248.60-0.012-0.0120.00510.03350.25950.8768--33,807.22-48.00---59.36--69.85---185.00--2.52-3.740.00---70.55---811.51------
MiMedx Group Inc256.26m-27.87m307.88m811.00------1.20-0.2487-0.24872.300.69441.443.636.84315,980.30-12.07-7.76-16.02-12.1583.3686.74-8.38-4.203.17-2.760.38--4.183.1380.29---13.21--
Utah Medical Products, Inc.51.24m15.98m314.75m178.0019.902.9313.596.144.364.3613.9929.650.43992.8810.74287,848.3013.7213.7714.2614.3662.2062.5731.1831.6916.13--0.0038.0016.304.5333.694.05-30.081.84
Zynex Inc.142.99m19.72m332.60m774.0017.334.8814.742.330.49970.49973.591.781.412.306.20184,746.8019.4126.6522.4733.7180.2879.7113.7916.902.9892.510.1652--62.6357.8188.48201.1921.93--
Vuzix Corp11.84m-45.49m361.55m106.00--2.75--30.53-0.7145-0.71450.18612.060.07751.028.55111,734.10-29.77-55.33-30.87-60.6915.682.36-384.05-280.3913.50-856.220.00--13.6743.98-101.80--17.29--
Iradimed Corp47.81m12.20m369.67m110.0030.485.6126.697.730.96520.96523.785.250.6322.287.80434,658.5016.129.3917.5710.2977.7576.1425.5116.1910.37--0.000.0031.835.171,538.925.27-13.42--
Orthofix Medical Inc461.98m-36.95m391.07m1.09k--1.14--0.8465-1.86-1.8623.2017.100.95881.366.14425,004.60-7.67-1.53-9.23-1.9073.7077.14-8.00-1.601.953.420.0558--14.252.54-1,624.79--2.60--
SmileDirectClub Inc541.41m-99.54m397.76m3.20k--2.82--0.7347-0.8318-0.83184.520.36230.65194.232.84169,190.90-38.95---33.66--70.28---59.74--2.26-29.541.48---2.92---30.72------
Akoya Biosciences Inc64.42m-62.89m402.80m149.00--4.42--6.25-1.68-1.681.722.410.32992.566.92201,949.80-32.35---37.31--60.72---98.08--3.16-18.530.3256--29.39---103.89------
SurModics, Inc.97.93m-12.84m405.86m389.00--3.24--4.14-0.9226-0.92267.058.940.55512.196.01251,758.40-7.281.77-8.392.0380.7084.37-
AxoGen Inc128.20m-31.64m465.97m428.00--4.57--3.63-0.7581-0.75813.072.410.63061.556.65299,537.40-15.56-16.05-17.51-18.3680.2680.83-24.68-22.983.71-185.120.308--13.4125.38-13.45--89.66--
Inogen Inc353.27m-28.36m522.27m1.02k--1.46--1.48-1.25-1.2515.5015.590.72976.1210.38346,002.90-5.864.67-6.705.3047.4348.07-8.035.454.75--0.000.0016.0512.03-8.65--67.40--
Nano-X Imaging Ltd5.31m-76.78m531.02m186.00--2.02--99.97-1.51-1.510.10495.020.0196----28,559.14-28.38---31.01---97.63---1,445.48------0.0136-------41.04------
Data as of Oct 04 2022. Currency figures normalised to SmileDirectClub Inc's reporting currency: US Dollar USD

Institutional shareholders

20.16%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 30 Jun 20228.88m7.33%
Prentice Capital Management LPas of 30 Jun 20227.15m5.91%
BlackRock Fund Advisorsas of 30 Jun 20221.47m1.21%
SSgA Funds Management, Inc.as of 30 Jun 20221.16m0.96%
Citigroup Global Markets, Inc. (Broker)as of 30 Jun 20221.15m0.95%
Morgan Stanley & Co. LLCas of 30 Jun 20221.08m0.89%
Geode Capital Management LLCas of 30 Jun 20221.01m0.83%
Camber Capital Management LPas of 30 Jun 20221.00m0.83%
Susquehanna Financial Group LLLPas of 30 Jun 2022792.92k0.66%
Sculptor Capital LPas of 30 Jun 2022726.70k0.60%
More ▼
Data from 30 Jun 2022 - 30 Jun 2022Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.